Socapalm / Safacam: Socfinaf cuts investments by 22% and writes down biological assets in Cameroon

Luxembourg agro-industrial group Socfinaf, which operates in Cameroon through Socapalm and Safacam, cut its asset acquisitions in the country by 22% in 2025 to €14.86 million, down from €19.06 million in 2024. It also recorded an impairment of about €1.2 million on its biological assets in Cameroon. The decline mainly affected tangible fixed assets, whose acquisition costs fell 30.9%, from €15.43 million to €10.66 million. By contrast, capitalized spending on biological assets rose 15.9% to €4.20 million.